Alexandra Nassar

Dr. Alexandra Nassar

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2022 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
ANAlexandra Nassar
Alexandra Nassar
STStylianos Tzedakis
Stylianos Tzedakis
RSRémy Sindayigaya
Rémy Sindayigaya
CHChristian Hobeika
Christian Hobeika
UMUgo Marchese
Ugo Marchese
DFDavid Fuks
David Fuks

1 September 2020 in Surgery
Verified
Journal Article
Closed access
ANAlexandra Nassar
Alexandra Nassar
CHChristian Hobeika
Christian Hobeika
CLChristian Lamer
Christian Lamer
MBMarc Beaussier
Marc Beaussier
ASAnthony Sarran
Anthony Sarran
DFDavid Fuks
David Fuks

8 May 2021 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
ANAlexandra Nassar
Alexandra Nassar
ETEcoline Tribillon
Ecoline Tribillon
UMUgo Marchese
Ugo Marchese
NFNicole Faermark
Nicole Faermark
SBStéphane Bonnet
Stéphane Bonnet
DFDavid Fuks
David Fuks

4 May 2023 in HPB
Verified
Journal Article
Closed access
RSRémy Sindayigaya
Rémy Sindayigaya
STStylianos Tzedakis
Stylianos Tzedakis
ETEcoline Tribillon
Ecoline Tribillon
CGChloé Gavignet
Chloé Gavignet
AMAlessandro Mazzotta
Alessandro Mazzotta
DFDavid Fuks
David Fuks

11 April 2023 in Surgery
Verified
Journal Article
Closed access
ANAlexandra Nassar
Alexandra Nassar
STStylianos Tzedakis
Stylianos Tzedakis
UMUgo Marchese
Ugo Marchese
ADAlix Dhote
Alix Dhote
MDMohamed Sabri Dallel
Mohamed Sabri Dallel
DFDavid Fuks
David Fuks

10 January 2023 in Cancers
Verified
Journal Article
Open access
PDF file
ANAlexandra Nassar
Alexandra Nassar
STStylianos Tzedakis
Stylianos Tzedakis
ADAlix Dhote
Alix Dhote
MSMarie Strigalev
Marie Strigalev
RCRomain Coriat
Romain Coriat
David FuksDavid Fuks
David Fuks
Over the past decades, liver cancer’s minimally invasive approach has primarily become as a new standard of oncological care. Colorectal liver metastases (CRLM) are one of the most developed indications of laparoscopic liver resection (LLR). CRLM resection is still the best treatment known in terms of survival. As multiple CRLM are found in up to 80% of cases at diagnosis (Manfredi S. and al, Annals of Surgery 2006), a lot of possible technical management approaches are described. With the development of the parenchymal-sparing strategy, multiple concomitant laparoscopic liver resections (LLR) are gaining acceptance. However, no recommendation is available regarding its indications and feasibility. Also, laparoscopic two-stage hepatectomy is developing for bilobar CRLM, and this also does not have established recommendation. The purpose of this paper was to highlight novelty and updates in the field of multiple minimally invasive liver resections. A review of the international literature was performed. The feasibility of laparoscopic concomitant multiple LLR and two-stage hepatectomy for CRLM as well as their outcomes were discussed. These clarifications could further guide the implementation of minimal resection in multiple colorectal liver metastases therapies.